FDA Drug Application (021630) for VFEND by PF PRISM CV

Back to FDA Applications sponsored by PF PRISM CV

Application Number021630
Product Number001
FormFOR SUSPENSION;ORAL
Dosage200MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVFEND
Active IngredientVORICONAZOLE

Active IngredientCount
List of drugs with Active Ingredient VORICONAZOLE2


Back to FDA Applications sponsored by PF PRISM CV